Top Sector Life Sciences & Health (LSH) entails a broad scope of disciplines, from pharmaceuticals to medical technology and from healthcare infrastructure to vaccination. To realise its mission – vital citizens in a healthy economy - the Top Sector builds on the strengths of the Dutch LSH sector to address the biggest societal challenges in prevention, cure and care. By funding multidisciplinary public-private partnerships (PPPs) the Top Sector aims to facilitate innovation. Here we give an overview of  a number of funded R&D projects by Top Sector LSH. The page is updated continuously.

150 projects

  • Harnessing immune cells for immunoprotection in children with cardiovascular risk

    Exploring the potential of Natural Killer T-cells as a novel therapeutic target for cardiovascular disease.
  • Development of innovative, personalized cancer vaccines

    Treating and/or preventing cancer recurrence through personalized and tumor-specific DNA vaccines.
  • Bioelectronic medicines to control inflammatory biological processes and treat IBD

    Design of electrical probes for the implementation of bioelectronic medicines to control and treat inflammatory biological processes.
  • Characterisation of Biomarkers for Non-Alcoholic Steatohepatitis

    Characterization of clinical biomarkers in mice to bridge the gap between pre-clinical studies and patients
  • Happy and healthy workers with renewed occupational health services

    Renewed Occupational Health Services to increase sustainable employability of workers in installation and technical businesses.
  • Analysis of Rheumatoid Arthritis-specific autoantibody profiles to improve treatment

    Relevance of RA-associated autoantibody profiles to predict benefit of intervention with biologicals in patient subgroups.
  • Faster registration of new drugs by label free human mass balance studies

    Speed up drug development and registration by conducting label-free human mass balance studies.